• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

营养保健品和草药通过靶向严重急性呼吸综合征冠状病毒2(SARS-CoV-2)降低2019冠状病毒病(COVID-19)风险并改善其治疗效果

Nutraceuticals and Herbs in Reducing the Risk and Improving the Treatment of COVID-19 by Targeting SARS-CoV-2.

作者信息

Tagde Priti, Tagde Sandeep, Tagde Pooja, Bhattacharya Tanima, Monzur Shams Minhaz, Rahman Md Habibur, Otrisal Pavel, Behl Tapan, Ul Hassan Syed Shams, Abdel-Daim Mohamed M, Aleya Lotfi, Bungau Simona

机构信息

Bhabha Pharmacy Research Institute, Bhabha University, Bhopal 462026, India.

PRISAL Foundation, Pharmaceutical Royal International Society, Bhopal 462042, India.

出版信息

Biomedicines. 2021 Sep 18;9(9):1266. doi: 10.3390/biomedicines9091266.

DOI:10.3390/biomedicines9091266
PMID:34572452
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8468567/
Abstract

The worldwide transmission of acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as a deadly or devastating disease is known to affect thousands of people every day, many of them dying all over the planet. The main reason for the massive effect of COVID-19 on society is its unpredictable spread, which does not allow for proper planning or management of this disease. Antibiotics, antivirals, and other prescription drugs, necessary and used in therapy, obviously have side effects (minor or significant) on the affected person, there are still not clear enough studies to elucidate their combined effect in this specific treatment, and existing protocols are sometimes unclear and uncertain. In contrast, it has been found that nutraceuticals, supplements, and various herbs can be effective in reducing the chances of SARS-CoV-2 infection, but also in alleviating COVID-19 symptoms. However, not enough specific details are yet available, and precise scientific studies to validate the approved benefits of natural food additives, probiotics, herbs, and nutraceuticals will need to be standardized according to current regulations. These alternative treatments may not have a direct effect on the virus or reduce the risk of infection with it, but these products certainly stimulate the human immune system so that the body is better prepared to fight the disease. This paper aims at a specialized literary foray precisely in the field of these "cures" that can provide real revelations in the therapy of coronavirus infection.

摘要

严重急性呼吸综合征冠状病毒2(SARS-CoV-2)作为一种致命或具有毁灭性的疾病在全球范围内传播,每天都有数千人受到影响,其中许多人在世界各地死亡。新型冠状病毒肺炎(COVID-19)对社会产生巨大影响的主要原因是其不可预测的传播,这使得无法对该疾病进行适当的规划或管理。抗生素、抗病毒药物和其他用于治疗的处方药,显然会对患者产生副作用(轻微或严重),目前仍没有足够明确的研究来阐明它们在这种特定治疗中的联合作用,而且现有方案有时也不明确和不确定。相比之下,人们发现营养保健品、补充剂和各种草药不仅可以有效降低感染SARS-CoV-2的几率,还可以缓解COVID-19的症状。然而,目前还没有足够具体的细节,根据现行法规,需要对验证天然食品添加剂、益生菌、草药和营养保健品的既定益处的精确科学研究进行规范。这些替代疗法可能不会对病毒产生直接影响或降低感染风险,但这些产品肯定会刺激人体免疫系统,使身体更好地准备抗击疾病。本文旨在专门深入研究这些“疗法”领域,以便在冠状病毒感染治疗方面提供真正有启发性的内容。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18fc/8468567/f8d0325cc8f3/biomedicines-09-01266-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18fc/8468567/ac4ca76f18e7/biomedicines-09-01266-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18fc/8468567/f0f2c881ffb4/biomedicines-09-01266-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18fc/8468567/f8d0325cc8f3/biomedicines-09-01266-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18fc/8468567/ac4ca76f18e7/biomedicines-09-01266-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18fc/8468567/f0f2c881ffb4/biomedicines-09-01266-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18fc/8468567/f8d0325cc8f3/biomedicines-09-01266-g003.jpg

相似文献

1
Nutraceuticals and Herbs in Reducing the Risk and Improving the Treatment of COVID-19 by Targeting SARS-CoV-2.营养保健品和草药通过靶向严重急性呼吸综合征冠状病毒2(SARS-CoV-2)降低2019冠状病毒病(COVID-19)风险并改善其治疗效果
Biomedicines. 2021 Sep 18;9(9):1266. doi: 10.3390/biomedicines9091266.
2
Dietary Supplements and Nutraceuticals under Investigation for COVID-19 Prevention and Treatment.正在接受新冠病毒预防和治疗研究的膳食补充剂与营养保健品
mSystems. 2021 May 4;6(3):e00122-21. doi: 10.1128/mSystems.00122-21.
3
Nutraceuticals as immune-stimulating therapy to fight COVID-19. Combination of elements to improve the efficacy.营养保健品作为免疫刺激疗法来对抗 COVID-19。联合使用元素以提高疗效。
Eur Rev Med Pharmacol Sci. 2020 Sep;24(17):9182-9187. doi: 10.26355/eurrev_202009_22869.
4
Pathogenesis-directed therapy of 2019 novel coronavirus disease.针对 2019 新型冠状病毒病的发病机制导向治疗。
J Med Virol. 2021 Mar;93(3):1320-1342. doi: 10.1002/jmv.26610. Epub 2020 Nov 10.
5
Non-pharmacological remedies for upper respiratory diseases in the pandemic COVID-19 era.大流行 COVID-19 时代治疗上呼吸道疾病的非药物疗法。
J Biol Regul Homeost Agents. 2020 Nov-Dec;34(6 Suppl. 1):41-49.
6
Rescue of SARS-CoV-2 from a Single Bacterial Artificial Chromosome.从单个细菌人工染色体中拯救 SARS-CoV-2。
mBio. 2020 Sep 25;11(5):e02168-20. doi: 10.1128/mBio.02168-20.
7
The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.新冠疫苗的快速研发和早期成功为加速癌症治疗机制带来了希望。
Arch Razi Inst. 2021 Mar;76(1):1-6. doi: 10.22092/ari.2021.353761.1612. Epub 2021 Mar 1.
8
COVID-19 and oncological disease.COVID-19 与肿瘤疾病。
Klin Onkol. 2021 Spring;34(3):211-219. doi: 10.48095/ccko2021211.
9
A Reminder of Skin Cancer During the COVID-19 Pandemic.新冠疫情期间对皮肤癌的提醒。
Acta Dermatovenerol Croat. 2021 Apr;291(1):58.
10
Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CL Reporter Assay.基于荧光的高通量 SARS-CoV-2 3CL 报告酶测定法的建立。
J Virol. 2020 Oct 27;94(22). doi: 10.1128/JVI.01265-20.

引用本文的文献

1
Physiochemically and Genetically Engineered Bacteria: Instructive Design Principles and Diverse Applications.理化遗传修饰细菌:设计原理与多样应用
Adv Sci (Weinh). 2024 Aug;11(30):e2403156. doi: 10.1002/advs.202403156. Epub 2024 Jun 12.
2
The Multisystem Impact of Long COVID: A Comprehensive Review.长新冠的多系统影响:全面综述
Diagnostics (Basel). 2024 Jan 24;14(3):244. doi: 10.3390/diagnostics14030244.
3
Phytochemicals of as a Future Promising Drug against SARS-CoV-2: Pharmacological Role, Molecular Mechanism, Molecular Docking Evaluation, and Efficient Delivery.

本文引用的文献

1
Artificial intelligence as a fundamental tool in management of infectious diseases and its current implementation in COVID-19 pandemic.人工智能作为传染病管理的基本工具及其在 COVID-19 大流行中的当前应用。
Environ Sci Pollut Res Int. 2021 Aug;28(30):40515-40532. doi: 10.1007/s11356-021-13823-8. Epub 2021 May 25.
2
Triggers, Timescales, and Treatments for Cytokine-Mediated Tissue Damage.细胞因子介导的组织损伤的触发因素、时间尺度和治疗方法。
Euro Med J Innov. 2021 Feb;5(1):52-62. doi: 10.33590/emjinnov/20-00203. Epub 2020 Dec 9.
3
(L.) Dunal: Opportunity for Clinical Repurposing in COVID-19 Management.
作为一种未来有望对抗新型冠状病毒的药物的植物化学物质:药理作用、分子机制、分子对接评估及高效递送
Microorganisms. 2023 Apr 12;11(4):1000. doi: 10.3390/microorganisms11041000.
4
The landscape of potential health benefits of carotenoids as natural supportive therapeutics in protecting against Coronavirus infection.类胡萝卜素作为天然辅助治疗剂在预防冠状病毒感染方面的潜在健康益处的前景。
Biomed Pharmacother. 2022 Oct;154:113625. doi: 10.1016/j.biopha.2022.113625. Epub 2022 Aug 31.
5
Novel and Alternative Therapeutic Strategies for Controlling Avian Viral Infectious Diseases: Focus on Infectious Bronchitis and Avian Influenza.控制禽类病毒感染性疾病的新型及替代治疗策略:聚焦传染性支气管炎和禽流感
Front Vet Sci. 2022 Jul 22;9:933274. doi: 10.3389/fvets.2022.933274. eCollection 2022.
6
Involvement of Resveratrol against Brain Cancer: A Combination Strategy with a Pharmaceutical Approach.白藜芦醇对抗脑癌的作用:一种联合药物治疗策略。
Molecules. 2022 Jul 21;27(14):4663. doi: 10.3390/molecules27144663.
7
Impact on the Nutritional Status and Inflammation of Patients with Cancer Hospitalized after the SARS-CoV-2 Lockdown.SARS-CoV-2 封锁后住院癌症患者的营养状况和炎症的影响。
Nutrients. 2022 Jul 2;14(13):2754. doi: 10.3390/nu14132754.
8
Long COVID-19 in Children: From the Pathogenesis to the Biologically Plausible Roots of the Syndrome.儿童长新冠:从发病机制到该综合征的生物学可能根源。
Biomolecules. 2022 Apr 8;12(4):556. doi: 10.3390/biom12040556.
9
Autism-like symptoms by exposure to air pollution and valproic acid-induced in male rats.暴露于空气污染和丙戊酸诱导雄性大鼠出现类似自闭症症状。
Environ Sci Pollut Res Int. 2022 Aug;29(39):59263-59286. doi: 10.1007/s11356-022-19865-w. Epub 2022 Apr 6.
10
Nanomedicine-Based Delivery Strategies for Breast Cancer Treatment and Management.基于纳米医学的乳腺癌治疗与管理递药策略。
Int J Mol Sci. 2022 Mar 5;23(5):2856. doi: 10.3390/ijms23052856.
(L.)杜纳尔:新冠病毒疾病管理中临床药物新用途的机会。
Front Pharmacol. 2021 May 3;12:623795. doi: 10.3389/fphar.2021.623795. eCollection 2021.
4
Comparative Study of Chemical Composition and Antioxidant Activity of Essential Oils and Crude Extracts of Four Characteristic Herbs.四种特色草药精油与粗提物的化学成分及抗氧化活性比较研究
Plants (Basel). 2021 Mar 8;10(3):501. doi: 10.3390/plants10030501.
5
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews.《PRISMA 2020声明:报告系统评价的更新指南》
J Clin Epidemiol. 2021 Jun;134:178-189. doi: 10.1016/j.jclinepi.2021.03.001. Epub 2021 Mar 29.
6
Withanone from Attenuates SARS-CoV-2 RBD and Host ACE2 Interactions to Rescue Spike Protein Induced Pathologies in Humanized Zebrafish Model.Withanone 抑制 SARS-CoV-2 RBD 与宿主 ACE2 的相互作用,挽救人源化斑马鱼模型中 Spike 蛋白诱导的病理损伤。
Drug Des Devel Ther. 2021 Mar 11;15:1111-1133. doi: 10.2147/DDDT.S292805. eCollection 2021.
7
Persons with Co-Existing Neurological Disorders: Risk Analysis, Considerations and Management in COVID-19 Pandemic.患有共病神经系统疾病的患者:COVID-19 大流行中的风险分析、考虑因素和管理。
CNS Neurol Disord Drug Targets. 2022;21(3):228-234. doi: 10.2174/1871527320666210308113457.
8
Probiotics: A potential immunomodulator in COVID-19 infection management.益生菌:COVID-19 感染管理中的潜在免疫调节剂。
Nutr Res. 2021 Mar;87:1-12. doi: 10.1016/j.nutres.2020.12.014. Epub 2021 Feb 13.
9
Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statement.更新系统评价报告指南:PRISMA 2020 声明的制定。
J Clin Epidemiol. 2021 Jun;134:103-112. doi: 10.1016/j.jclinepi.2021.02.003. Epub 2021 Feb 9.
10
Does COVID-19-related cachexia mimic cancer-related cachexia? Examining mechanisms, clinical biomarkers, and potential targets for clinical management.新型冠状病毒肺炎相关恶病质是否类似于癌症相关恶病质?探究其机制、临床生物标志物及临床管理的潜在靶点。
J Cachexia Sarcopenia Muscle. 2021 Apr;12(2):519-522. doi: 10.1002/jcsm.12681. Epub 2021 Feb 7.